Search for Clinical Trial Results

Sponsored By

Glucose Transporter Type 1 Deficiency Syndrome - 13 Studies Found

Status Study
Active, not recruiting Study Name: Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Date: 2013-10-31
Interventions:
  • Drug: UX007 (triheptanoin) Tri
Recruiting Study Name: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Date: 2014-01-13
Interventions: Drug: Triheptanoin Schedule A: Subjects previously treated
Recruiting Study Name: Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Date: 2016-11-07
Interventions:
  • Drug: UX007 UX007 is a liquid

Enrolling by invitation Study Name: Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS
Condition: Glucose Transporter Type 1 Deficiency Syndrome
Date: 2015-11-03
Interventions: Drug: UX007 UX007 is a liquid intended for oral (PO) administration.
Recruiting Study Name: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
Condition: Glut1 Deficiency Syndrome
Date: 2013-12-03
Interventions: Drug: GLUT1 DS
Active, not recruiting Study Name: Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome
Condition: Glucose Transporter Type 1 Deficiency Syndrome
Date: 2013-11-27
Interventions: Drug: Triheptanoin Triheptanoin (C7 oil) is a triglyceride of the anaplerotic odd-chain fatty acid hepto
Not yet recruiting Study Name: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
Condition:
  • Glucose Transporter Type 1 Deficiency Syndrome
  • Glucose Transporter Type 1 Deficiency Syndrome
  • Glut1 Deficiency Syndrome
  • Glucose Transpo
    Date: 2013-12-11
    Interventions: Drug: Triheptanoin Other Names:
    • C7 oil
    • Heptanoate
    • hep
Completed Study Name: Evaluation of Keyo in Children With Epilepsy
Condition:
  • Intractable Epilepsy
  • Glucose Transporter Type 1 Deficiency Syndrome Date: 2016-09-19
    Interventions: Dietary Supplement: Keyo Keyo is a Food for Special Medical Purposes (FSMP) and is intended for use in t
Next >>>